Adjuvant for vaccine immunotherapy of cancer–focusing on Toll‐like receptor 2 and 3 agonists for safely enhancing antitumor immunity

T Seya, H Shime, Y Takeda, M Tatematsu… - Cancer …, 2015 - Wiley Online Library
Immune‐enhancing adjuvants usually targets antigen (Ag)‐presenting cells to tune up
cellular and humoral immunity. CD 141+ dendritic cells (DC) represent the professional Ag …

Adjuvant for vaccine immunotherapy of cancer–focusing on Toll‐like receptor 2 and 3 agonists for safely enhancing antitumor immunity

T Seya, H Shime, Y Takeda, M Tatematsu… - Cancer …, 2015 - search.proquest.com
Immune‐enhancing adjuvants usually targets antigen (Ag)‐presenting cells to tune up
cellular and humoral immunity. CD 141+ dendritic cells (DC) represent the professional Ag …

Adjuvant for vaccine immunotherapy of cancer--focusing on Toll-like receptor 2 and 3 agonists for safely enhancing antitumor immunity

T Seya, H Shime, Y Takeda, M Tatematsu… - Cancer …, 2015 - pubmed.ncbi.nlm.nih.gov
Immune-enhancing adjuvants usually targets antigen (Ag)-presenting cells to tune up
cellular and humoral immunity. CD141 (+) dendritic cells (DC) represent the professional Ag …

Adjuvant for vaccine immunotherapy of cancer–focusing on Toll‐like receptor 2 and 3 agonists for safely enhancing antitumor immunity

T Seya, H Shime, Y Takeda, M Tatematsu… - Cancer Science, 2015 - cir.nii.ac.jp
抄録< jats: p> Immune‐enhancing adjuvants usually targets antigen (Ag)‐presenting cells to
tune up cellular and humoral immunity.< jats: styled-content style=" fixed-case"> CD</jats …

[HTML][HTML] Adjuvant for vaccine immunotherapy of cancer–focusing on Toll‐like receptor 2 and 3 agonists for safely enhancing antitumor immunity

T Seya, H Shime, Y Takeda, M Tatematsu… - Cancer …, 2015 - ncbi.nlm.nih.gov
Immune‐enhancing adjuvants usually targets antigen (Ag)‐presenting cells to tune up
cellular and humoral immunity. CD 141+ dendritic cells (DC) represent the professional Ag …

[PDF][PDF] Adjuvant for vaccine immunotherapy of cancer–focusing on Toll-like receptor 2 and 3 agonists for safely enhancing antitumor immunity

T Seya, H Shime, Y Takeda, M Tatematsu… - Cancer Sci, 2015 - cyberleninka.org
Immune adjuvants represent substances that enhance immune activation in conjunction with
antigens (Ag).(1) Their functions include the physical effect on Ag to stay longer in tissue or …

Adjuvant for vaccine immunotherapy of cancer--focusing on Toll-like receptor 2 and 3 agonists for safely enhancing antitumor immunity.

T Seya, H Shime, Y Takeda, M Tatematsu… - Cancer …, 2015 - europepmc.org
Immune‐enhancing adjuvants usually targets antigen (Ag)‐presenting cells to tune up
cellular and humoral immunity. CD 141+ dendritic cells (DC) represent the professional Ag …

[PDF][PDF] Adjuvant for vaccine immunotherapy of cancer–focusing on Toll-like receptor 2 and 3 agonists for safely enhancing antitumor immunity

T Seya, H Shime, Y Takeda, M Tatematsu… - Cancer Sci, 2015 - Citeseer
Immune adjuvants represent substances that enhance immune activation in conjunction with
antigens (Ag).(1) Their functions include the physical effect on Ag to stay longer in tissue or …

[引用][C] Adjuvant for vaccine immunotherapy of cancer-focusing on Toll-like receptor 2 and 3 agonists for safely enhancing antitumor immunity

T SEYA, H SHIME, Y TAKEDA… - Cancer Science …, 2015 - jglobal.jst.go.jp
Adjuvant for vaccine immunotherapy of cancer - focusing on Toll-like receptor 2 and 3
agonists for safely enhancing antitumor immunity | Article Information | J-GLOBAL Art J-GLOBAL …